Neurological Wilson’s Disease Signs—Hepatic Encephalopathy or Copper Toxicosis?
Open Access
- 27 February 2023
- journal article
- review article
- Published by MDPI AG in Diagnostics
- Vol. 13 (5) , 893
Abstract
Wilson’s disease (WD) is a rare autosomal recessive (AR) disorder resulting from mutations in the ATP7B gene, which is responsible for the encryption of transmembrane copper transporting ATPase. The symptomatic presentation of the disease is estimated to be about 1 in 30,000. The impairment of ATP7B function results in a copper overload in hepatocytes, which further leads to liver pathology. This copper overload also occurs in other organs, most particularly in the brain. This could then cause the occurrence of neurological and psychiatric disorders. Symptoms differ substantially and most often occur between the ages of 5 and 35 years. Early symptoms are commonly hepatic, neurological, or psychiatric. While disease presentation is most often asymptomatic, it could also range as far as to include fulminant hepatic failure, ataxia, and cognitive disorders. Various treatments are available for Wilson’s disease, including chelation therapy and zinc salts, which can reverse copper overload through different mechanisms. In select cases, liver transplantation is recommended. New medications, such as tetrathiomolybdate salts, are currently being investigated in clinical trials. With prompt diagnosis and treatment, prognosis is favorable; however, diagnosing patients before the onset of severe symptoms is a significant concern. Early screening for WD could help in diagnosing patients earlier and improving treatment outcomes.Keywords
This publication has 92 references indexed in Scilit:
- Quality of Life and Psychiatric Symptoms in Wilson’s Disease: the Relevance of Bipolar DisordersClinical Practice & Epidemiology in Mental Health, 2012
- The Effect of Hepatic Encephalopathy, Hepatic Failure, and Portosystemic Shunt on Brain Volume of Cirrhotic Patients: A Voxel-Based Morphometry StudyPLOS ONE, 2012
- Bipolar disorders and Wilson’s diseaseBMC Psychiatry, 2012
- Posttraumatic stress symptoms and health-related quality of life: a two year follow up study of injury treated at the emergency departmentBMC Psychiatry, 2012
- Brain edema dynamics in patients with overt hepatic encephalopathyA magnetic resonance imaging studyNeuroImage, 2010
- Neurologic Wilson's diseaseAnnals of the New York Academy of Sciences, 2010
- A novel Global Assessment Scale for Wilson's Disease (GAS for WD)Movement Disorders, 2009
- Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's diseaseMovement Disorders, 2008
- Sleep in patients with treated Wilson's disease. A questionnaire studyNordic Journal of Psychiatry, 2002
- Dystonia in Wilson's diseaseMovement Disorders, 2001